Comment
doi: 10.1001/jamainternmed.2021.0395.
Tocilizumab in Treatment for Patients With COVID-19
Affiliations
- PMID: 33818612
- DOI: 10.1001/jamainternmed.2021.0395
Item in Clipboard
Comment
Tocilizumab in Treatment for Patients With COVID-19
JAMA Intern Med.
.
No abstract available
Comment in
-
Tocilizumab in Treatment for Patients With COVID-19-Reply.JAMA Intern Med. 2021 Jul 1;181(7):1019-1020. doi: 10.1001/jamainternmed.2021.0404. JAMA Intern Med. 2021. PMID: 33818607 No abstract available.
Comment on
-
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.JAMA Intern Med. 2021 Jan 1;181(1):24-31. doi: 10.1001/jamainternmed.2020.6615. JAMA Intern Med. 2021. PMID: 33080005 Free PMC article. Clinical Trial.
-
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.JAMA Intern Med. 2021 Jan 1;181(1):32-40. doi: 10.1001/jamainternmed.2020.6820. JAMA Intern Med. 2021. PMID: 33080017 Free PMC article. Clinical Trial.
Similar articles
-
Tocilizumab: From Rheumatic Diseases to COVID-19.Curr Pharm Des. 2021;27(13):1597-1607. doi: 10.2174/1381612827666210311141512. Curr Pharm Des. 2021. PMID: 33719967 Review.
-
Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment.Mult Scler Relat Disord. 2020 Nov;46:102592. doi: 10.1016/j.msard.2020.102592. Epub 2020 Oct 21. Mult Scler Relat Disord. 2020. PMID: 33296987 Free PMC article.
-
Tocilizumab administration in patients with SARS-CoV-2 infection: Subcutaneous injection vs intravenous infusion.J Med Virol. 2021 Jan;93(1):69-70. doi: 10.1002/jmv.26124. Epub 2020 Jun 19. J Med Virol. 2021. PMID: 32492210 Free PMC article. No abstract available.
-
Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection.Respir Care. 2022 May;67(5):629-630. doi: 10.4187/respcare.10067. Respir Care. 2022. PMID: 35473844 No abstract available.
-
Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis.J Infect. 2022 Mar;84(3):418-467. doi: 10.1016/j.jinf.2021.11.013. Epub 2021 Nov 20. J Infect. 2022. PMID: 34808242 Free PMC article. No abstract available.
Cited by
-
Optimisation of anti-interleukin-6 therapy: Precision medicine through mathematical modelling.Front Immunol. 2022 Jul 19;13:919489. doi: 10.3389/fimmu.2022.919489. eCollection 2022. Front Immunol. 2022. PMID: 35928820 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
